http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110041244-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2018-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110041244-B |
| titleOfInvention | Co-amorphous compound of donepezil and valsartan and preparation method, composition and use thereof |
| abstract | The invention discloses a co-amorphous compound formed by combining donepezil (English name: donepezil, such as formula (I)) and valsartan (English name: valsartan, such as formula (II)) by non-covalent bonds and its preparation Methods and compositions and uses thereof. Specifically, the present invention discloses the state form of the co-amorphous compound formed by donepezil and valsartan; the preparation method of the co-amorphous compound formed by donepezil and valsartan; the co-amorphous compound formed by donepezil and valsartan; As a pharmaceutical active ingredient in the preparation of various prevention and/or treatment of heart failure, myocardial ischemia, hypertension, vascular disease, angina pectoris, hyperlipidemia, atherosclerosis and other cardiovascular diseases and neurodegenerative diseases such as Alzheimer's disease Application in the drug of Zheimer's disease and diseases complicated by the above-mentioned various diseases. (I) Donepezil molecular structural formula (II) Molecular structural formula of valsartan. |
| priorityDate | 2018-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.